Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · Real-Time Price · USD

2.815

-0.335 (-10.63%)

At close: Mar 18, 2026, 4:00 PM EDT

2.890

+0.075 (2.66%)

After-hours: Mar 18, 2026, 7:40 PM EDT

Galectin Therapeutics Employees

Galectin Therapeutics had 15 employees as of December 31, 2024. The number of employees increased by 1 or 7.14% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

7.14%

Revenue / Employee

n/a

Profits / Employee

-$2,496,133

Market Cap

181.49M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2024	15	1	7.14%
Dec 31, 2023	14	2	16.67%
Dec 31, 2022	12	3	33.33%
Dec 31, 2021	9	3	50.00%
Dec 31, 2020	6	2	50.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
MacroGenics	341
Sutro Biopharma	178
ProQR Therapeutics	166
Zentalis Pharmaceuticals	166
Cibus	159
Adagene	138
Prelude Therapeutics	131
Arcturus Therapeutics Holdings	111